0.595
price up icon0.00%   0.00
after-market Dopo l'orario di chiusura: .59 -0.005 -0.84%
loading

Briacell Therapeutics Corp Azioni (BCTX) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-01-31 2023-10-31 2023-07-31 2023-04-30 2023-01-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
15.60%
9.8294
8.503 - 5.677 4.4863
Depreciation and Amortization
0.03%
0.00382
0.00382 - - -
Operating Income/Loss
15.60%
-9.8294
-8.503 -7.7058 -5.677 -4.4863
Nonoperating Income/Loss
110.28%
-1.4861
14.46 5.2871 0.7816 -7.3954
Income/Loss From Continuing Operations Before Tax
290.20%
-11.33
5.9589 -2.4187 -4.8954 -11.88
Income/Loss From Continuing Operations After Tax
290.20%
-11.33
5.9589 -2.4187 -4.8954 -11.88
Net Income/Loss
290.20%
-11.33
5.9589 -2.4187 -4.8954 -11.88
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
7.88%
-0.0393
-0.0427 - - -
Basic Average Shares
0.00%
15.98
15.98 0.1016 15.52 15.52
Diluted Average Shares
4.16%
15.98
16.67 0.1016 15.52 15.52
Basic Earnings Per Share
286.84%
-0.71
0.38 - - -0.77
Diluted Earnings Per Share
42.00%
-0.71
-0.50 -0.15 -0.32 -0.77
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$18.98
price up icon 3.66%
$76.97
price up icon 1.45%
$39.51
price up icon 7.22%
$359.21
price down icon 1.11%
$187.69
price down icon 0.81%
$101.87
price up icon 2.16%
Capitalizzazione:     |  Volume (24 ore):